glp-1 serotonin Frontiers GLP-1's have been a powerful
Description
The progression to type-2 diabetes is invariably associated with a decline in functional -cell mass [[526], [527], [528], [529], [530]]
Both compounds should be viewed as long-term or potentially lifelong therapies rather than short-term interventions
Patients should know these warning risks: Low blood sugar: GLP-1 medicines rarely cause low blood sugar alone
The network analysis was performed using R (version 4.1.2, updated by 21 November 2021) netmeta package
Secondly, the enteroendocrine cell density was measured by manual counting
